Cymbiotika
PrivateLast Round
Seed
Nov 6, 2025
Total Funding Raised
$55M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Cymbiotika operates in Consumer & Commerce and is based in San Diego, California. Its latest recorded funding round was a Seed round in November 2025.
Cymbiotika is a health and wellness company that develops and sells nutritional supplements designed to address nutritional deficiencies and support healthy aging.
Sector
Consumer & Commerce
Verticals
D2C Brands, E-commerce, Sports & Fitness, Fashion & Beauty
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cymbiotika Comparables
Compare Cymbiotika with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ritual | 89% | |
| Snap Supplements | 87% | |
| The Absorption Company | 86% |
For institutional investors. Book with your work email.
Cymbiotika Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cymbiotika Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RevTek Capital | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 30% month-over-month.
- Mar 13, 2026
Partnered with Ulta Beauty to launch supplements online and in stores.
For institutional investors. Book with your work email.
Cymbiotika Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cymbiotika's valuation, stock price, and market status.
Is Cymbiotika a public or private company?
Cymbiotika is a private company.
What is the current stock price of Cymbiotika?
Cymbiotika is a private company, so its shares have no public market price. Caplight tracks Cymbiotika's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cymbiotika worth (valuation)?
Valuation information for Cymbiotika is not publicly available.
Can I buy Cymbiotika stock?
Cymbiotika shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cymbiotika's last funding round?
Cymbiotika's most recent funding round was Seed on November 6, 2025.
Who are the main investors in Cymbiotika?
Key investors in Cymbiotika include RevTek Capital.
Will Cymbiotika IPO soon?
No public IPO plans have been announced for Cymbiotika.
How can I track Cymbiotika secondary market activity?
Caplight tracks bids, offers, and trades in Cymbiotika's shares on secondary markets.